Back
IGC Pharma, Inc. 10K Form
Sell
17
IGC
IGC Pharma, Inc.
Last Price:
$0.30
Seasonality Move:
2.63%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive IGC News And Ratings
See the #1 stock for the next 7 days that we like better than IGC
IGC Financial Statistics
Sales & Book Value
| Annual Sales: | $1.3M |
|---|---|
| Cash Flow: | $-2.4M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.09 |
| Price / Book: | 3.47 |
Profitability
| EPS (TTM): | -0.07780 |
|---|---|
| Net Income (TTM): | $-6.4M |
| Gross Margin: | $52K |
| Return on Equity: | -94.42% |
| Return on Assets: | -70.25% |
IGC Pharma, Inc. Earnings Forecast
Key IGC Pharma, Inc. Financial Ratios
-
The Gross Profit Margin over the past 20 years for IGC is 4.09%.
-
The Selling, General & Administrative Expenses for IGC have been equal to 346.97% of Gross Profit Margin.
-
The Research & Development expenses have been 287.57% of Revenue.
-
The Net Earning history of IGC is -560.27% of Total Revenues.
-
Per Share Earnings over the last 20 years have been positive in 10 years.
IGC Pharma, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NYAM |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | IGC |
| CUSIP: | 45408X |
| Website: | igcpharma.com |
Debt
| Debt-to-Equity Ratio: | 0.02 |
|---|---|
| Current Ratio: | 1.32 |
| Quick Ratio: | 0.78 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
IGC Technical Analysis vs Fundamental Analysis
Sell
17
IGC Pharma, Inc. (IGC)
is a Sell
Is IGC Pharma, Inc. a Buy or a Sell?
-
IGC Pharma, Inc. stock is rated a SellThe current IGC Pharma, Inc. [IGC] share price is $0.31. The Score for IGC is 17, which is 66% below its historic median score of 50, and infers higher risk than normal.